Answers are grounded in this paper and cite their sources.
Demonstrates olanzapine's ability to reduce opioid-related behaviors in an experimental model, suggesting therapeutic potential.
OLZ attenuates morphine-induced CPP and downregulates D2R expression in the HIP without affecting general locomotor function. These findings suggest a potential therapeutic role for OLZ in the management of opioid-related behaviors. Further research is needed to determine its clinical relevance.
No takes yet. Share an insight, caveat, or question.
Firozjaei et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: